Fred Hutch statement regarding the FDA approval of CD19 immunotherapy, lisocabtagene maraleucel
Hutch News,
SEATTLE — Feb. 5, 2021 — Today the U.S. Food and Drug Administration approved the chimeric antigen receptor immunotherapy…
Fred Hutch statement regarding the FDA approval of CD19 immunotherapy, lisocabtagene maraleucel | sciencenewsnet.in
Sciencenewsnet.in,
Post Views: 1 SEATTLE Feb. 5, 2021 Today the U.S. Food and Drug Administration approved the chimeric antigen receptor…
Building a better CAR: emerging high-throughput in vitro tools for CAR selection and optimization
BioInsights,
Introduction Chimeric antigen receptors (CARs) were originally devised by recombining antibody variable regions with TCR…